Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An integrative prognostic and immune analysis of PTPRD in cancer

1 Jan 2022

Abstract excerpt

PTPRD plays an indispensable role in the occurrence of multiple tumors. However, pan-cancer analysis is unavailable. The purpose of this research was to preliminarily study its prognostic landscape across various tumors and investigate its relationship with immunotherapy. We exhibited the expression profile, survival analysis, and genomic alterations of PTPRD based on the TIMER, GEPIA, UALCAN, PrognoScan and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Protein Tyrosine Phosphatases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35603359
DOI: 10.3934/mbe.2022251

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An integrative prognostic and immune analysis of PTPRD in cancerPMID 35603359Read ↗

An Integrative Prognostic and Immune Analysis of PTPRD in Pan-CancerSemantic proximity Read ↗

Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancersSemantic proximity Read ↗

PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types.Semantic proximity Read ↗

Pan-cancer analysis of the prognostic and immunological roles of SHP-1/ptpn6Semantic proximity Read ↗

PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer.Semantic proximity Read ↗

PTPRC as a pan-cancer biomarker: Prognostic significance and immune microenvironment interactionsSemantic proximity Read ↗

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC.Semantic proximity Read ↗

The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancersSemantic proximity Read ↗

Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.Semantic proximity Read ↗

Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung AdenocarcinomaSemantic proximity Read ↗

Pan-cancer analysis of PTPN6: prognostic significance and functional implications in tumor progressionSemantic proximity Read ↗

The expression patterns and the prognostic roles of PTPN family members in digestive tract cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.